secwatch / observer
8-K filed August 30, 2024, 7:59 PM ET CIK 0001850079
leadership confidence high sentiment neutral materiality 0.60

Five directors resign from Telesis Bio board, CEO becomes chair

Telesis Bio Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jami Nachtsheim

Director
Telesis Bio Inc.
Effective
2024-08-27
Filed
August 30, 2024, 7:59 PM ET
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
Departed

Annette Tumolo

Director
Telesis Bio Inc.
Effective
2024-08-27
Filed
August 30, 2024, 7:59 PM ET
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
Departed

Todd R. Nelson

Director
Telesis Bio Inc.
Effective
2024-08-29
Filed
August 30, 2024, 7:59 PM ET
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
Departed

Franklin R. Witney

Director
Telesis Bio Inc.
Effective
2024-08-27
Filed
August 30, 2024, 7:59 PM ET
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
Departed

Christine A. Tsingos

Director
Telesis Bio Inc.
Effective
2024-08-27
Filed
August 30, 2024, 7:59 PM ET
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
Appointed

Eric Esser

Chair of the Board
Telesis Bio Inc.
Filed
August 30, 2024, 7:59 PM ET
the Board appointed Eric Esser, the Company’s President and CEO, to serve as the chair of the board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jami Nachtsheim resigned as Director at Telesis Bio Inc..

Action
resigned
Role
Director
Exact text from the filing
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Annette Tumolo resigned as Director at Telesis Bio Inc..

Action
resigned
Role
Director
Exact text from the filing
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Todd R. Nelson resigned as Director at Telesis Bio Inc..

Action
resigned
Role
Director
Exact text from the filing
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Franklin R. Witney resigned as Director at Telesis Bio Inc..

Action
resigned
Role
Director
Exact text from the filing
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Christine A. Tsingos resigned as Director at Telesis Bio Inc..

Action
resigned
Role
Director
Exact text from the filing
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Esser was appointed as Chair of the Board at Telesis Bio Inc..

Action
appointed
Role
Chair of the Board
Exact text from the filing
the Board appointed Eric Esser, the Company’s President and CEO, to serve as the chair of the board
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-24-102461
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.